Ouro Medicines (Series A)

Funding Details
Awarder
Inbox
Date Award
January 10, 2025
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$120,000,000
Company Info
Traction
Raised $120 million in Series A funding.
Organizations Involved
GSK, Monograph Capital, NEA, TPG Life Sciences Innovations
Founders
Jaideep Dudani
Company Description
Ouro Medicines is a biotechnology startup focused on developing antibody drugs for chronic inflammatory conditions using T cell engagers to rebalance the immune systems of people with autoimmune diseases.
Market
Autoimmune diseases
Location
USA
Coinvestors
GSK, Monograph Capital, NEA, TPG Life Sciences Innovations
Links
Back to Home Back to Biotechnology Deals View Funding Announcement